发明授权
US08859783B2 Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
有权
靛玉红-3'-肟衍生物作为有效的细胞周期蛋白依赖性激酶抑制剂
- 专利标题: Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
- 专利标题(中): 靛玉红-3'-肟衍生物作为有效的细胞周期蛋白依赖性激酶抑制剂
-
申请号: US13576105申请日: 2011-01-28
-
公开(公告)号: US08859783B2公开(公告)日: 2014-10-14
- 发明人: Yong-Chul Kim , Jae-Il Kim , Soo-Ho Ban , Soon-Young Jeong , Soo-Jeong Choi , Jung-Eun Lee
- 申请人: Yong-Chul Kim , Jae-Il Kim , Soo-Ho Ban , Soon-Young Jeong , Soo-Jeong Choi , Jung-Eun Lee
- 申请人地址: KR Jeollanam-Do
- 专利权人: Anygen Co., Ltd.
- 当前专利权人: Anygen Co., Ltd.
- 当前专利权人地址: KR Jeollanam-Do
- 代理机构: Kenyon & Kenyon LLP
- 优先权: KR10-2010-0010715 20100205
- 国际申请: PCT/KR2011/000611 WO 20110128
- 国际公布: WO2011/096676 WO 20110811
- 主分类号: C07D209/38
- IPC分类号: C07D209/38 ; A61K31/404 ; C07D403/04
摘要:
The present invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
公开/授权文献
信息查询